Articles On Anteo Diagnostics (ASX:ADO)

AnteoTech (ASX:ADO) has announced it has received CE Mark registration for its EuGeni Reader and the in vitro rapid diagnostic test for the detection of SARS-CoV-2 nucleocapsid antigen, the COVID-19 ART.

It’s a case of back-to-back wins for nanotech stock AnteoTech Ltd [ASX:ADO]. The ADO share price is rising for a different reason. With the ongoing efforts of a novel COVID-19 test responsible for the upbeat outlooks. The post Green-light...

It has been a subdued start to the week for the S&P/ASX 200 Index (ASX: XJO). In late morning trade, the benchmark index is down 0.3% to 6,972.1 points. Four ASX shares that are not letting that hold them back today are listed below. H...

The Anteotech Ltd (ASX: ADO) share price surged 8% higher at the open after a key update on European regulation for its rapid COVID-19 test. At the time of writing, the AnteoTech share price is trading at 27 cents, up 6%. Why is the AnteoT...

Small caps have gained for a sixth straight day, even as their larger peers declined. The Small Ordinaries index of Australia’s 101st to 300th biggest companies finished the week up 6.7 points, or 0.2 per cent, to a fresh 13-year high of 3,...

It’s not every day you’ll stumble across a company as exciting as AnteoTech Ltd [ASX:ADO]. The ADO share price rising 6.25% not because of a pandemic solution, but because of batteries... The post AnteoTech Share Price Up on Mega-Battery P...

 The Anteotech Ltd (ASX: ADO) share price is up 9% this morning, after the company shared news it is to be a part of a major battery project. AnteoTech will be the supplier of silicon composite to the Super Anode Project, a 4-year project...

In late morning trade on Friday the S&P/ASX 200 Index (ASX: XJO) has run out of steam and is tumbling lower. At the time of writing, the benchmark index is down 0.3% to 6,976.5 points. Four ASX shares that are not letting that hold the...

 Source: jo.pix, Shutterstock Summary The ASX 200 has surged sharply so far this year, rising by 1.8% in March alone. The recent rise in the Australian stock market has triggered demand of high-potential shares among investors. Piedm...

The market may be pushing higher in 2021, but its modest gain is nothing in comparison to those recorded by the two ASX shares listed below. Here’s why these ASX shares have doubled in value this year: AnteoTech Ltd (ASX: ADO) The AnteoT...

Source: katjen, Shutterstock Summary Another round of lockdown, increased restrictions on business activities is kicking in, making the markets fearful again. Afterpay’s share has been one of the best performers during the pandemic, a...

Source: whiteMocca, Shutterstock The S&P/ASX 200 gained substantially and closed 0.66% higher at A$6,752.50 on Monday backed by a few outperforming stocks. The ASX All Ordinaries closed at A$6,995.00, 0.51% higher. The small caps drop...

AnteoTech [ASX:ADO] share price is up 17% at time of writing after a clinical study shows AnteoTech’s COVID-19 test can meet WHO’s guidelines. The AnteoTech share price is up 152% ... The post AnteoTech Share Price is Up on COVID-19 Test Ne...

AnteoTech [ASX:ADO] share price is up 17% at time of writing after a clinical study shows AnteoTech’s COVID-19 test can meet WHO’s guidelines. The AnteoTech share price is up 152% ... The post AnteoTech Share Price is Up on COVID-19 Test Ne...

Source: ITTIGallery ,Shutterstock Summary Red Sky Energy has clocked a massive volume of over 178 million shares. Resources and Energy Group has skyrocketed by 22.5 per cent to A$0.049. Anteotech’s share price has opened with a gap u...

In early afternoon trade on Monday the S&P/ASX 200 Index (ASX: XJO) has fought back from a poor start and is pushing higher. At the time of writing, the benchmark index is up 0.45% to 6,737.6 points. Four ASX shares that are climbing m...

The AnteoTech Ltd (ASX: ADO) share price has rocketed more than 15% higher this morning. Shares in the Aussie biotech are on the charge after an update on its rapid COVID-19 test. Why is the AnteoTech share price surging? The strong upswin...

Source: Josep Suria, Shutterstock  Healthcare, one of the biggest and most convoluted sectors in the trade market, is made up of a wide assortment of companies dealing with pharma, medical, fitness and other healthcare facilities and produ...

The Anteotech Ltd (ASX: ADO) share price gained a whopping 43.18% today, closing the day trading at 32 cents. AnteoTech is a surface chemistry company with intellectual property in its core technology product groups. These include AnteoCoa...

Ellume has been a company on every investors’ lips over the past couple of months. The Brisbane-based medical company has been at the vanguard of Australia’s contribution to fighting the coronavirus pandemic. The company has pioneered an ‘...

Summary The total capital raised on the Australian benchmark equity index dipped to A$1.07 billion in January 2011, down from A$1.3 billion in the corresponding period last year.  While the average daily number of traders was down 8 pe...

AnteoTech Limited (ASX:ADO) has responded sharply on the back of a public announcement informing the market about a $304 million contract bagged by its customer Ellume from the Pentagon for its Emergency Use Authorization (EUA) COVID-19 at...

Nanotech play Anteotech (ASX:ADO) enjoyed a day out today, finishing the day up 8.5c or 85% to finish at 18.5c. ... Read More The post Chart of the Day: US Defense link boosts Anteotech (ASX:ADO) to 85pc rise appeared first on Stockhead.

The AnteoTech Ltd (ASX: ADO) share price has returned from its trading halt and rocketed higher on Wednesday. In afternoon trade, the nanotechnology company’s shares surged a massive 95% higher to a record high of 19.5 cents. Why did the A...

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: ADO) have risen by more than 70 per cent today on the news that customer Ellume bagged a $304 million US Government contract. Ellume, founded by 2020 Brisbane Young Entrepren...

Shares in Brisbane-based nanotechnology company AnteoTech (ASX: ADO) have risen by more than 70 per cent today on the news that customer Ellume bagged a $304 million US Government contract. As announced in October last year, Ellume is a c...

For an unlisted company, Ellume certainly knows how to keep ASX investors talking. The Brisbane-based health company also made news last year. This was due to its announcement that the United States Food and Drug Administration (FDA) had e...

AnteoTech's (ASX: ADO) plans to bring a rapid COVID-19 test to the market have been given a significant shot in the arm through a $1.4 million Queensland Government grant, demonstrating Brisbane's strength as an emerging biotech hub in the...

Summary Queensland Government has awarded funds worth ~A$1.4 million to AnteoTech for its COVID-19 Antigen Rapid Test development. The grant is a strong endorsement of ADO’s development and commercialisation progress. The Company is l...

Summary ASX-listed surface chemistry company AnteoTech is working to facilitate the technology transfer for increasing manufacturing of its COVID-19 test. The Company has commenced the clinical trial of COVID-19 test with VIDRL. Anteo...

24 Dec 2020 - AnteoTech (ASX:ADO) are pushing forward to release their Covid-19 antigen rapid test towards market launch.

ASX large cap biotech Mesoblast (ASX:MSB) is not alone in fighting Acute Respiratory Distress Syndrome (ARDS). ARDS is a disease that hinders the lungs’ ability to operate and is a major culprit of COVID-19 deaths. Essentially it causes lun...

At the time of writing the AnteoTech Ltd [ASX:ADO] share price trades at 10.5 cents, up 5%. AnteoTech announced the company received a cash refund, under the Federal Government’s research and development tax incentive scheme... The post Ant...

27 Nov 2020 - AnteoTech (ASX:ADO) has received a tax refund of almost $1.2 million under the Federal Government’s Research & Development Tax Incentive Scheme.

The AnteoTech Ltd (ASX: ADO) share price is rocketing higher today. This comes after the company announced a design freeze on its COVID-19 Antigen Rapid Test (ART) following successful results. At the time of writing, the Anteotech share p...

AnteoTech (ASX:ADO) says it has received the results of an independent validation study of its COVID-19 Antigen Rapid Test using stored patient swab samples.

The AnteoTech Ltd (ASX: ADO) share price has been a disappointing performer on Wednesday. In afternoon trade the biotech company’s shares are sinking 12% lower to 11 cents. Why is the Anteotech share price sinking lower? Investors have bee...

Buy the dip. Sound investment advice, or a mug’s game? Depending on your approach, it could fall to either side of that line. Timing the market to buy at the lows, or sell at the highs, is educated guess work at best. Which is why you’ll b...

The good news keeps on coming for stocks working on COVID-19 treatments. The latest company to confirm some good news is AnteoTech Ltd [ASX:ADO]. A small-cap biotech firm that has been working on a product that tests for COVID-19 symptoms.....

The Anteotech Ltd (ASX: ADO) share price is up 18.75% in late afternoon trading, after initially leaping by nearly 23% this morning. The surge in the Anteotech share price comes on the heels of the company’s announcement to the ASX just af...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The market...

AnteoTech Ltd’s [ASX:ADO] share price has rocketed up today after it emerged from a trading halt with news it will develop a COVID-19 detection platform. Shares in ADO are up 77.27% or 1.7 cents at the time of writing to trade at 3.9 cents...

A quick wrap of the ASX’s key winners and losers on Thursday, July 16. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 604 stocks rose, 684 de...

One of the inconveniences of COVID-19 tests is that they can take several hours to complete. A number of ASX stocks are attempting to create faster tests, including two that surged this morning. AnteoTech Ltd (ASX:ADO), which said it has es...

Technologies developed in Brisbane and Melbourne may contribute to a new 15-minute test for COVID-19, harnessing nanocoating to speed up results for saliva and blood tests. Brisbane-based AnteoTech (ASX: ADO) has successfully developed a...

Surface chemistry company AnteoTech (ASX: ADO) emerged from a trading halt this morning to announce a potential breakthrough in the struggle against COVID-19. The company revealed it has developed a proof of concept COVID-19 and flu multipl...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

Queensland-based chemistry company AnteoTech (ASX: ADO) has signed a non-binding heads of agreement with German pharmaceutical and life sciences company Merck to co-develop products for the world’s rapidly-growing point of care diagnostic t...

AnteoTech (ADO) has delivered a solid quarter of development and advanced key business relationships The company’s new cross-linked binder development is progressing quickly and has gathered market interest Feedback will be used for coll...